Navigation Links
A 'bionic nose' that knows
Date:3/30/2009

Both cancer cells and the chemicals used to make bombs can foil detection because they appear in trace amounts too small for conventional detection techniques. Tel Aviv University has developed the ultimate solution: a molecule that can magnify weak traces of "hidden" molecules into something we can detect and see.

Using molecular techniques in nanotechnology, Prof. Doron Shabat of TAU's Raymond and Beverly Sackler School of Chemistry has engineered new molecules that have the power to identify targets -- such as biomarkers in cancer, materials in explosives, or pollutants in water --even when present in miniscule amounts. Prof. Shabat's invention, like a bionic nose, can "sniff out" these trace molecules and amplify them tenfold, making them noticeable for doctors and crimefighters.

Details of Prof. Shabat's project appeared in a paper published in the journal Chemical Communication last year.

Fights Chemical and Biological Threats In Our Bodies and Environment

Prof. Shabat, a bioorganic chemist, plans to develop the technology so that it amplifies signals millions and billions times stronger than they are. "We are developing a molecular system that amplifies certain events," says Prof. Shabat. "That way we'll be able to respond faster to medical, security and environmental threats. In effect, our device can amplify just about any chemical system that has a certain kind of reactivity."

"It has the potential to help doctors diagnose diseases -- those with biomarkers, and enzymatic activities that are compatible with our molecular probe," says Prof. Shabat. "The long list includes a few kinds of cancer, as well, including prostate cancer. But it also has applications for testing for impurities in water. It has both biological and non-biological applications."

A Track-and-Trace Solution

Prof. Shabat's invention is a molecular sensor that acts in a solution. A chemist would add trace amounts of the test material from the field -- a spoonful of contaminated drinking water, for example -- into the solution and would simply see if the color of the solution changes. If so, the targeted material -- the cancer, or explosive, or pollutant -- is present.

As of now, Prof. Shabat's is a unique solution. The prototype is ready, and Prof. Shabat plans to use it to "amplify" problems around the world to improve healthcare, safety, and security. Some of the research behind the new invention was done in collaboration with the Scripps Research Institute in San Diego.


'/>"/>

Contact: George Hunka
ghunka@aftau.org
212-742-9070
American Friends of Tel Aviv University
Source:Eurekalert

Related medicine news :

1. Bioniche Responds to Australian Equine Influenza Outbreak
2. Bioniche Receives $2 Million Government Grant For Market Development Related to its E. coli O157:H7 Cattle Vaccine
3. Bioniche Food Safety Vaccine Receives Global Top Honours in Industry Excellence Awards
4. Bioniche Receives Comment from USDA on a Field Trial for E. coli O157:H7 Cattle Vaccine
5. Media Advisory - Bioniche Discusses USDA Comment on E. coli O157:H7 Cattle Vaccine Field Trial
6. Bioniche to Present at Rodman & Renshaw 9th Annual Healthcare Conference
7. Bioniche Reports Fiscal 2008 First Quarter
8. Bioniche Receives $5 Million of Federal Government Support to Scale-up Vaccine Production in Ontario
9. Bioniche Amends Terms of Convertible Debt with Laurus Master Funds
10. USDA Agrees to Grant Conditional License to Bioniche for its E. coli O157:H7 Cattle Vaccine
11. Bioniche Reports Fiscal 2008 Second Quarter
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... ... 12, 2017 , ... CitiDent and San Francisco dentists, Dr. ... Oventus O2Vent technology. As many as 18 million Americans are estimated to suffer ... Oral appliances can offer significant relief to about 75 percent of people with ...
(Date:10/12/2017)... , ... October 12, 2017 , ... IsoComforter, Inc. ( ... announced today the introduction of an innovative new design of the shoulder pad. ... you get maximum comfort while controlling your pain while using cold therapy. By utilizing ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information ... we intend to develop to enable prevention of a major side effect of ... loss, especially in pediatric patients. For cisplatin, hearing loss is FDA listed on-label ...
(Date:10/12/2017)... ... October 12, 2017 , ... Leading pediatric oncology experts at ... for the 49th Congress of the International Society of Paediatric Oncology (SIOP) ... Center for Cancer and Blood Disorders at Children’s National, and Stephen P. ...
(Date:10/12/2017)... ... October 12, 2017 , ... Health Literacy ... health literacy software tool, and the Cancer Patient Education Network (CPEN), an independent ... today announce a new strategic alliance. , As CPEN’s strategic partner, HLI ...
Breaking Medicine News(10 mins):
(Date:10/11/2017)... -- Caris Life Sciences ® , a leading innovator in ... medicine, today announced that St. Jude Medical Center,s Crosson ... as its 17 th member. Through participation with ... Institute will help develop standards of care and best ... cancer treatment more precise and effective. ...
(Date:10/7/2017)... , Oct. 6, 2017   Provista, ... more than $100 billion in purchasing power, today announced ... and information. The Newsroom is the online ... industry trends, infographics, expert bios, news releases, slideshows and ... access to a wealth of resources at their fingertips, ...
(Date:10/2/2017)... FLINT, Mich. , Oct. 2, 2017 ... acquired 8th Day Software and Consulting, LLC , ... 8th Day Software, based in Tennessee ... Management LLC. 8th Day expands EnvoyHealth,s service offerings for ... product development. "In ...
Breaking Medicine Technology: